VITRO DIAGNOSTICS COM USD0.001 (VODG)

0.07
0.01 7.69
OTC
Prev Close 0.07
Open 0.06
Day Low/High 0.06 / 0.07
52 Wk Low/High 0.02 / 0.12
Volume 6.30K
Exchange OTC
Shares Outstanding 20.39B
Market Cap 1.33M
Div & Yield N.A. (N.A)

Frost & Sullivan Honors Vitro Biopharma For Its Outstanding Technological Innovations And Business Strategy In The Stem Cell Tools Industry

The company aims to increase the market penetration of its proprietary MSC-based research products, while expanding its stem cell segment to include differentiated cells derived from MSCs

Vitro Biopharma Introduces New Products For Personalized Cellular Medicine

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, has recently introduced several new products for use of an individual’s own cells ( http://tinyurl.

Vitro Develops Novel Stem Cell Technology For Use In Treatment Of Hearing Loss

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced development of technical advancements with application to treatment of hearing loss in animals and human through commercialization of a variety of...

Vitro Launches New Stem Cell Products For Clinical Use & Presents Webinar With HemoGenix®, Inc.

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the commercial launch of several new stem cell products including those with application to clinical studies.

Vitro Appoints Accomplished Finance Executive To Its Advisory Board

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, is pleased to announce the appointment of Duane C.

Vitro Announces Progress In The Achievement Of Profitability: Income Increases While Debt And Expenses Are Reduced

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced progress and achievement of key financial goals in the transformation of the Company from a research operation to a profitable commercial...

Vitro Out-licenses Patents, Products & Technology For Treatment Of Infertility

Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the signing of a patent license granting exclusive rights to two of its United States patents and an option to a third patent to Dr.

New Results Reveal Extensive Competitive Advantages Of VitroGrow™ Stem Cell Culture Media

Vitro Diagnostics, Inc. (OTCBB: VODG) (OTCQB: VODG), dba Vitro Biopharma, announced completion of studies comparing its mesenchymal stem cell culture media, VitroGrow™, to major competitors showing distinct...

Vitro Expands HemoGenix Alliance To Include Cell-based Testing For Liver Toxicity

Vitro Diagnostics, Inc. (OTCBB: VODG)(OTCQB: VODG), dba Vitro Biopharma, announced that it signed an amendment to its contract to jointly manufacture and distribute stem cell analysis tools with HemoGenix ®, Inc.

Vitro Enters Contract To Develop Stem Cell-Derived Food

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced that it has entered into a contract with Mokshagundam Biotechnologies, a private research organization established to develop alternative meat ...

Vitro And HemoGenix® Launch New Products At An International Stem Cell Meeting

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, and HemoGenix ®, Inc.

Vitro CEO Interviews With Wall Street Reporter Regarding New Stem Cell Tools For Cellular Medicine

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced that its CEO, Dr.

Vitro Appoints Prominent Denver Investment Banker To Its Board Of Directors

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced the appointment of Richard Huebner to its Board of Directors.

Vitro Co-sponsors Keystone Stem Cell Symposium

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced that it is co-sponsoring a Keystone Symposium on Molecular and Cellular Biology entitled “Stem Cell Differentiation and De-Differentiation.